BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 22094469)

  • 21. A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice.
    Gault VA; Bhat VK; Irwin N; Flatt PR
    J Biol Chem; 2013 Dec; 288(49):35581-91. PubMed ID: 24165127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin action in the double incretin receptor knockout mouse.
    Ayala JE; Bracy DP; Hansotia T; Flock G; Seino Y; Wasserman DH; Drucker DJ
    Diabetes; 2008 Feb; 57(2):288-97. PubMed ID: 17977951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.
    Burmeister MA; Ayala JE; Smouse H; Landivar-Rocha A; Brown JD; Drucker DJ; Stoffers DA; Sandoval DA; Seeley RJ; Ayala JE
    Diabetes; 2017 Feb; 66(2):372-384. PubMed ID: 27908915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
    Chan SW; Lin G; Yew DT; Rudd JA
    Eur J Pharmacol; 2011 Oct; 668(1-2):340-6. PubMed ID: 21756894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
    Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice.
    Kooijman S; Wang Y; Parlevliet ET; Boon MR; Edelschaap D; Snaterse G; Pijl H; Romijn JA; Rensen PC
    Diabetologia; 2015 Nov; 58(11):2637-46. PubMed ID: 26254578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
    Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
    Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency.
    Chen M; Mema E; Kelleher J; Nemechek N; Berger A; Wang J; Xie T; Gavrilova O; Drucker DJ; Weinstein LS
    Endocrinology; 2011 Sep; 152(9):3343-50. PubMed ID: 21771891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
    Vahl TP; Tauchi M; Durler TS; Elfers EE; Fernandes TM; Bitner RD; Ellis KS; Woods SC; Seeley RJ; Herman JP; D'Alessio DA
    Endocrinology; 2007 Oct; 148(10):4965-73. PubMed ID: 17584962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.
    Cabou C; Campistron G; Marsollier N; Leloup C; Cruciani-Guglielmacci C; Pénicaud L; Drucker DJ; Magnan C; Burcelin R
    Diabetes; 2008 Oct; 57(10):2577-87. PubMed ID: 18633100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice.
    Irwin N; McClean PL; Hunter K; Flatt PR
    Diabetes Obes Metab; 2009 Jun; 11(6):603-10. PubMed ID: 19515180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A; Lovshin JA; Baggio LL; Drucker DJ
    Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling.
    Yang L; Yao D; Yang H; Wei Y; Peng Y; Ding Y; Shu L
    Mol Endocrinol; 2016 Mar; 30(3):361-71. PubMed ID: 26789107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
    Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
    J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of action of glucagon-like peptide 1 in the pancreas.
    Doyle ME; Egan JM
    Pharmacol Ther; 2007 Mar; 113(3):546-93. PubMed ID: 17306374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.
    Punjabi M; Arnold M; Rüttimann E; Graber M; Geary N; Pacheco-López G; Langhans W
    Endocrinology; 2014 May; 155(5):1690-9. PubMed ID: 24601880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
    Scrocchi LA; Marshall BA; Cook SM; Brubaker PL; Drucker DJ
    Diabetes; 1998 Apr; 47(4):632-9. PubMed ID: 9568697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.